Vantage Point: Strategies for sales reps

Ganesh Vedarajan

According to ZS Associates' Spring 2012 AccessMonitor report, 61% of oncologists place moderate-to-severe restrictions on sales-rep visits – despite the fact that the oncology field has almost twice as many new drugs in development as any other specialty.

In this Medical Marketing & Media article, ZS Principal Ganesh Vedarajan cites three strategies that will help pharma sales reps work around limited access issues and bring value to oncologists.